VCYT

25.4101.48%
JL

John Leite

Global Chief Commercial Officer

Dr. John Leite, Ph.D., is Global Chief Commercial Officer of Veracyte, Inc. from 2025. He served as Chief Commercial Officer since November 2024 until 2025 and was Chief Commercial Officer for CLIA Business at Veracyte, Inc since September 2023 until November 2024 and served as its Senior Vice President and General Manager of Pulmonology & Market Access from September 2022 until September 2023. He served as Chief Business Officer of InterVenn Biosciences Inc. since November 2020. He is commercial, partnership and market access strategy. Prior to that, he held leadership positions at Illumina from 2014 to 2020, where he initially served as vice president, Oncology, Market Development and Product Development and then as vice president, Clinical Business Development. Prior to Illumina, he was vice president of Commercial Strategy and Market Access at Genoptix Medical Laboratories. Dr. Leite received his B.S. in Biochemistry from Rutgers University and his Ph.D. in Biochemistry and Molecular Genetics at University of Pittsburgh, School of Medicine and completed post-doctoral work as a National Research Service Award Fellow at the California Institute of Technology.

公司职务